M Imad Damaj Selected Research

M Imad Damaj Research Topics

Disease

6	Pain (Aches) 01/2021 - 02/2011
5	Hyperalgesia 01/2018 - 05/2005
4	Inflammation (Inflammations) 09/2020 - 02/2011
3	Hypersensitivity (Allergy) 01/2021 - 04/2012
3	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 05/2005
3	Edema (Dropsy) 01/2019 - 02/2011
2	Colitis 09/2020 - 04/2012
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 02/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Chronic Pain 09/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018
1	Wounds and Injuries (Trauma) 05/2015
1	Schizophrenia (Dementia Praecox) 02/2013
1	Neuralgia (Stump Neuralgia) 02/2013
1	Alzheimer Disease (Alzheimer's Disease) 02/2013
1	Hypothermia 02/2011

Drug/Important Bio-Agent (IBA)

7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2020 - 05/2005
6	Nicotine FDA Link 01/2020 - 05/2005
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2017
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2020 - 04/2012
2	Dextrans (Dextran)FDA Link 09/2020 - 04/2012
2	Formaldehyde (Formol)FDA Link 01/2017 - 02/2011
1	Pharmaceutical PreparationsIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	N-acylethanolaminesIBA 01/2021
1	palmidrolIBA 01/2021
1	Conotoxins (Conotoxin)IBA 09/2020
1	Sirtuin 2IBA 01/2019
1	Freund's AdjuvantIBA 01/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019
1	desformylflustrabromineIBA 01/2018
1	Varenicline (Chantix)FDA Link 01/2018
1	SmokeIBA 01/2018
1	Complement System Proteins (Complement)IBA 02/2013
1	Synapsins (Synapsin I)IBA 02/2013
1	CalciumIBA 02/2013
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 02/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2013
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2013
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	1- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)ureaIBA 02/2013
1	Cholinergic Agents (Cholinergics)IBA 02/2013
1	CarrageenanIBA 02/2013
1	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 02/2013
1	Dronabinol (THC)FDA LinkGeneric 02/2011
1	O 3223IBA 02/2011
1	CB2 Cannabinoid ReceptorIBA 02/2011
1	CannabinoidsIBA 02/2011
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 02/2011
1	SulfonamidesIBA 02/2011
1	Drinking WaterIBA 05/2005

Therapy/Procedure

1	Therapeutics 01/2018
1	Analgesia 05/2015